Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Int J Dermatol ; 34(7): 510-3, 1995 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-7591422

RESUMEN

BACKGROUND: Adhesion molecules play a major role in the pathogenesis of inflammatory skin diseases by regulating lymphocyte trafficking and homing in an inflamed area. METHODS: The expression of the lymphocyte function-associated antigen-1 (LFA-1) and of its ligand, the intercellular adhesion molecule-1 (ICAM-1) has been studied in psoriatic skin lesions of 10 patients with guttate, nummular, and palmoplantar psoriasis. In addition, the peculiar immunophenotype of infiltrating cells (CD3, CD4, CD8, CD25) and their correlation with HLA-DR expression before and after treatment with oral cetirizine, a highly selective, third generation H1-receptor antagonist has been examined using the labeled avidin biotin (LAB) system. RESULTS: Cetirizine treatment modulated in vivo the expression of adhesion molecules LFA-1/CAM-1 as shown in all cases by decreased levels of their expression on keratinocytes and on dermal endothelial cells (P < 0.001). The expression of HLA-DR on keratinocytes and endothelial cells was also inhibited after treatment. The numbers of infiltrating CD3-, CD4-, CD8-positive cells were reduced, whereas there was no significant modification of CD25-positive cells within the epidermis and the dermis. CONCLUSION: This open clinical trial suggests that cetirizine could be effective in treating psoriasis: (1) for its symptomatic control on itching; (2) for its immunopharmacologic modulation of leukocyte integrins and on the immunophenotype pattern of infiltrating and resident cells, and (3) for contributing to the clearing of the lesions clinically.


Asunto(s)
Moléculas de Adhesión Celular/metabolismo , Cetirizina/uso terapéutico , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Psoriasis/tratamiento farmacológico , Psoriasis/inmunología , Administración Oral , Adulto , Biopsia , Moléculas de Adhesión Celular/análisis , Cetirizina/administración & dosificación , Antagonistas de los Receptores Histamínicos H1/administración & dosificación , Humanos , Inmunohistoquímica , Inmunofenotipificación , Persona de Mediana Edad , Psoriasis/diagnóstico , Resultado del Tratamiento
3.
Int J Dermatol ; 34(3): 177-80, 1995 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7751092

RESUMEN

BACKGROUND: The importance of eosinophils in the pathogenesis of the major forms of pemphigoid (bullous pemphigoid, cicatricial pemphigoid, herpes gestationis) remains to be confirmed. METHODS: To evaluate the role of eosinophilic infiltrates in these diseases and to detect the presence and activity of eosinophils, we compared the serum levels of eosinophil cationic protein (ECP), an eosinophil-derived protein, in 11 healthy subjects and in 10 patients with pemphigoid diseases (8 with bullous pemphigoid, one with cicatricial pemphigoid, and one with herpes gestationis). The serum of two patients with epidermolysis bullosa acquisita (EBA) and one with linear IgA bullous dermatosis (LABD) were utilized as a further control. RESULTS: There was a significant difference between the mean of serum ECP levels in patients with pemphigoid diseases (25.1 +/- 12.3 micrograms/L, M = SD) and control subjects (2.30 +/- 2.41, micrograms/L +/- SD 2.41) (T = 4.272 P < 0.0001). The two patients with EBA (10.8 and 17.7 micrograms/L) showed contrasting results; the patient with LABD had normal ECP serum levels. The serum levels of ECP were not significantly correlated with the blood eosinophil count (R = 0.103; P = 0.777) in any of the cases. CONCLUSIONS: In pemphigoid disease, the serum levels of ECP seem to be correlated with the activated secreting and tissue-damaging eosinophils found in the dermis, supporting the concept of an active participation of eosinophils in generating cutaneous lesions.


Asunto(s)
Proteínas Sanguíneas/análisis , Mediadores de Inflamación/sangre , Penfigoide Ampolloso/sangre , Ribonucleasas , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Proteínas en los Gránulos del Eosinófilo , Eosinófilos/patología , Eosinófilos/fisiología , Epidermólisis Ampollosa Adquirida/sangre , Epidermólisis Ampollosa Adquirida/patología , Femenino , Humanos , Inmunoglobulina A , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Penfigoide Gestacional/sangre , Penfigoide Gestacional/patología , Penfigoide Benigno de la Membrana Mucosa/sangre , Penfigoide Benigno de la Membrana Mucosa/patología , Penfigoide Ampolloso/patología , Embarazo , Enfermedades Cutáneas Vesiculoampollosas/sangre , Enfermedades Cutáneas Vesiculoampollosas/patología
4.
Artículo en Inglés | MEDLINE | ID: mdl-8073836

RESUMEN

Recent research has demonstrated the activity of calcipotriol, effective as a potent inhibitor of cellular proliferation and known to increase differentiation in a number of cell lines in the topical treatment of psoriasis. Vit D3 receptors are expressed in keratinocytes and vascular endothelial cells. We studied the alterations in basal keratinocytes (stem cells or anchoring cells) and endothelial cell modification in 6 patients with psoriasis treated with calcipotriol ointment twice a day for 4 weeks. The samples were embedded in Epon resin for thin section and ultrathin section examination by electron microscopy. A normal pattern of distribution of the two different types of basal keratinocytes was observed before treatment. After treatment, only anchoring cells were detected. The alterations of endothelial cells in capillary loop disappeared after treatment, presenting normal aspects. Our morphological findings suggest that calcipotriol is therapeutically effective, due principally to an inhibition of cellular proliferation.


Asunto(s)
Calcitriol/análogos & derivados , Fármacos Dermatológicos/uso terapéutico , Endotelio Vascular/ultraestructura , Queratinocitos/patología , Psoriasis/tratamiento farmacológico , Piel/irrigación sanguínea , Calcitriol/uso terapéutico , Capilares/ultraestructura , Humanos , Psoriasis/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...